Journal article · 2026 · Open access

Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles

Achim Biesel, Aparna Shandheep, Andreas Pavlou, Lena Mareike Busker, Marcus Koch, Vesa Kopliku, Katharina Maisel, Annette Boese, Jennifer Skerra, Lara‐Jasmin Schröder, Lavinia Neubert, Nicole Schneider‐Daum and 3 more

Journal of Controlled Release, 400(Pt A), 115509 · Published 31 October 2026 · DOI 10.1016/j.jconrel.2026.115509

Open full textCite this paper

In brief

“Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles” is a 2026 journal article by Achim Biesel and 14 co-authors, published in Journal of Controlled Release. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Controlled Release.

Citations
0
References
67
Authors
15

Abstract

Delivering mRNA to the lungs promises treatment of genetic, infectious and non-communicable lung diseases. Yet, conventional lipid nanoparticle formulations lack the stability needed to endure the harsh mechanical stress during nebulization. Additionally, once deposited in the respiratory tract, gene delivery systems may first have to overcome the mucus barrier, before actually transfecting the target cells. To overcome these challenges, we utilize lipid-polymer hybrid nanoparticles (LPH), merging the stability of pharmaceutical polymers with the transfection efficiency of cationic and ionizable lipids. LPH are produced in a robust microfluidic process, accomplish near-complete encapsulation efficiency, even after nebulization, and confer high transfection efficiency in A549 cells. To provide colloidal stability after aerosolization, we developed a coating strategy with hyaluronic acid (HA) and poly(vinyl alcohol) (PVA), ensuring ideal nebulization stability by steric shielding. This formulation showed good transfection efficiency of air-liquid interface grown Calu-3 cells, producing and covered by mucus. The potential of LPH to deliver mRNA to mammalian cells was first shown in primary human lung fibroblasts in vitro and could also be confirmed after intratracheal administration to mice in vivo. Together, these findings validate LPH as a versatile and aerosolizable mRNA delivery platform, overcoming the key technological and biological barriers in pulmonary gene delivery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Biesel, A., Shandheep, A., Pavlou, A., Busker, L. M., Koch, M., Kopliku, V., Maisel, K., Boese, A., Skerra, J., Schröder, L., Neubert, L., Schneider‐Daum, N., Loretz, B., Kalinke, U., & Lehr, C. (2026). Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles. Journal of Controlled Release, 400(Pt A), 115509. https://doi.org/10.1016/j.jconrel.2026.115509

MLA 9

Biesel, Achim, et al. “Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles.” Journal of Controlled Release, vol. 400, no. Pt A, 2026, p. 115509. https://doi.org/10.1016/j.jconrel.2026.115509.

Chicago

Biesel, Achim, Aparna Shandheep, Andreas Pavlou, Lena Mareike Busker, Marcus Koch, Vesa Kopliku, Katharina Maisel, et al. 2026. “Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles.” Journal of Controlled Release 400 (Pt A): 115509. https://doi.org/10.1016/j.jconrel.2026.115509.

Harvard

Biesel, A. et al. (2026) ‘Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles’, Journal of Controlled Release, 400(Pt A), p. 115509. doi:10.1016/j.jconrel.2026.115509.

IEEE

A. Biesel et al., “Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles,” Journal of Controlled Release, vol. 400, no. Pt A, p. 115509, 2026, doi: 10.1016/j.jconrel.2026.115509.

BibTeX

@article{biesel2026overcoming,
  title     = {{Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles}},
  author    = {Biesel, Achim and Shandheep, Aparna and Pavlou, Andreas and Busker, Lena Mareike and Koch, Marcus and Kopliku, Vesa and Maisel, Katharina and Boese, Annette and Skerra, Jennifer and Schröder, Lara‐Jasmin and Neubert, Lavinia and Schneider‐Daum, Nicole and Loretz, Brigitta and Kalinke, Ulrich and Lehr, Claus‐Michael},
  journal   = {Journal of Controlled Release},
  year      = {2026},
  volume    = {400},
  number    = {Pt A},
  pages     = {115509},
  doi       = {10.1016/j.jconrel.2026.115509},
  url       = {https://doi.org/10.1016/j.jconrel.2026.115509}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid-polymer hybrid nanoparticles
  • mucus barrier
  • hyaluronic acid coating
  • polyvinyl alcohol
  • steric shielding
  • ionizable lipids
  • cationic lipids
  • transfection efficiency

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Biesel, A., Shandheep, A., Pavlou, A., Busker, L. M., Koch, M., Kopliku, V., Maisel, K., Boese, A., Skerra, J., Schröder, L., Neubert, L., Schneider‐Daum, N., Loretz, B., Kalinke, U., & Lehr, C. (2026). Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles. Journal of Controlled Release, 400(Pt A), 115509. https://doi.org/10.1016/j.jconrel.2026.115509

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Controlled Release: sign in and open the full text from this page.

Who wrote this paper?

Achim Biesel, Aparna Shandheep, Andreas Pavlou, Lena Mareike Busker, Marcus Koch, Vesa Kopliku, Katharina Maisel, Annette Boese, Jennifer Skerra, Lara‐Jasmin Schröder, Lavinia Neubert, Nicole Schneider‐Daum and 3 more.

What is the DOI of this paper?

10.1016/j.jconrel.2026.115509, permanently at https://doi.org/10.1016/j.jconrel.2026.115509. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.